title: A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition.
abstract: Increased activity of the epithelial sodium channel (ENaC) in the respiratory airways contributes to the pathophysiology of cystic fibrosis (CF), a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In some patients suffering from atypical CF a mutation can be identified in only one CFTR allele. We recently identified in this group of CF patients a heterozygous mutation (W493R) in the alpha-subunit of ENaC. Here, we investigate the functional effects of this mutation by expressing wild-type alpha beta gamma ENaC or mutant alpha(W493R)beta gamma ENaC in Xenopus oocytes. The alpha W493R mutation stimulated amiloride-sensitive whole-cell currents (Delta I(ami)) by approximately 4-fold without altering the single-channel conductance or surface expression of ENaC. As these data suggest that the open probability (P(o)) of the mutant channel is increased, we investigated the proteolytic activation of ENaC by chymotrypsin. Single-channel recordings revealed that chymotrypsin activated near-silent channels in outside-out membrane patches from oocytes expressing wild-type ENaC, but not in membrane patches from oocytes expressing the mutant channel. In addition, the alpha W493R mutation abolished Na(+) self inhibition of ENaC, which might also contribute to its gain-of-function effects. We conclude that the alpha W493R mutation promotes constitutive activation of ENaC by reducing the inhibitory effect of extracellular Na(+) and decreasing the pool of near-silent channels. The resulting gain-of-function phenotype of the mutant channel might contribute to the pathophysiology of CF in patients carrying this mutation.
authors.affiliation: Department of Cellular and Molecular Physiology, Friedrich-Alexander University of Erlangen-Nürnberg, Germany.
authors.forename: Robert
authors.initials: R
authors.lastname: Rauh
authors.forename: Alexei
authors.initials: A
authors.lastname: Diakov
authors.forename: Anja
authors.initials: A
authors.lastname: Tzschoppe
authors.forename: Judit
authors.initials: J
authors.lastname: Korbmacher
authors.forename: Abul Kalam
authors.initials: AK
authors.lastname: Azad
authors.forename: Harry
authors.initials: H
authors.lastname: Cuppens
authors.forename: Jean-Jaques
authors.initials: JJ
authors.lastname: Cassiman
authors.forename: Jörg
authors.initials: J
authors.lastname: Dötsch
authors.forename: Heinrich
authors.initials: H
authors.lastname: Sticht
authors.forename: Christoph
authors.initials: C
authors.lastname: Korbmacher
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D002918:Chymotrypsin / Q000378:metabolism; D003550:Cystic Fibrosis / Q000503:physiopathology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000502:physiology; D053503:Epithelial Sodium Channels / Q000235:genetics* / Q000502:physiology*; D025461:Feedback, Physiological / Q000502:physiology; D005260:Female; D006801:Humans; D009154:Mutation / Q000235:genetics*; D009865:Oocytes / Q000166:cytology / Q000378:metabolism; D018408:Patch-Clamp Techniques; D010641:Phenotype; D010957:Plasmids; D012964:Sodium / Q000378:metabolism*; D014982:Xenopus laevis
chemical_list: D053503:Epithelial Sodium Channels; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D012964:Sodium; D002918:Chymotrypsin